Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024International Journal of Laboratory HematologyOpen Access

Variability in combinations of APTT reagent and substrate plasma for a one‐stage clotting assay to measure factor VIII products

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAtsuo SuzukiNagoya University HospitalNSNobuaki SuzukiSuzuki (Japan)TKTakeshi KanematsuSuzuki (Japan)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Suzuki et al. (2024) studied this question.

synapsesocial.com/papers/68e765e9b6db6435876daecfhttps://doi.org/10.1111/ijlh.14258
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII2023 · 7 citations
  2. 2A survey of one‐stage and chromogenic potencies in therapeutic factor VIII concentrates2002 · 46 citations
  3. 3Native specific activity of glutathione peroxidase (GPx-1), phospholipid hydroperoxide glutathione peroxidase (PHGPx) and glutathione reductase (GR) does not differ between normo- and hypomotile human sperm samples2004 · 1,685 citations
  4. 4Monitoring of different factor VIII replacement products using a factor VIII one‐stage clotting assay on cobas t 511/711 analysers2021 · 7 citations
  5. 5Measuring FVIII activity of glycopegylated recombinant factor VIII , N8‐ GP , with commercially available one‐stage clotting and chromogenic assay kits: a two‐centre study2017 · 44 citations